|
LAPTM4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.078600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.880000E-02 |
| Normal-vs-Stage2 |
1.819780E-03 |
| Normal-vs-Stage3 |
2.410200E-02 |
| Normal-vs-Stage4 |
2.776200E-03 |
| Stage1-vs-Stage2 |
3.986200E-02 |
| Stage1-vs-Stage3 |
6.141200E-01 |
| Stage1-vs-Stage4 |
1.484800E-01 |
| Stage2-vs-Stage3 |
1.060970E-01 |
| Stage2-vs-Stage4 |
3.727200E-01 |
| Stage3-vs-Stage4 |
4.054200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.695500E-02 |
| Normal-vs-AfricanAmerican |
4.621200E-01 |
| Normal-vs-Asian |
1.490200E-01 |
| Caucasian-vs-AfricanAmerican |
3.439400E-01 |
| Caucasian-vs-Asian |
5.288000E-01 |
| AfricanAmerican-vs-Asian |
6.520000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.975700E-03 |
| Normal-vs-Female |
1.316400E-02 |
| Male-vs-Female |
2.437000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.287900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.497500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.018040E-04 |
| Normal-vs-Age(81-100Yrs) |
3.949000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.593400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.939900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.854000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.435620E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.678400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.577600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.376500E-02 |
| Classical-VS-Follicular |
2.49879999999481E-05 |
| Classical-VS-Other |
3.524200E-01 |
| Classical-VS-Normal |
2.238800E-01 |
| Tall-VS-Follicular |
4.309900E-02 |
| Tall-VS-Other |
8.589200E-01 |
| Tall-VS-Normal |
2.825600E-02 |
| Follicular-VS-Other |
5.459600E-01 |
| Follicular-VS-Normal |
2.19320000000023E-05 |
| Other-VS-Normal |
1.722560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.966900E-04 |
| Normal-vs-N1 |
9.810800E-04 |
| N0-vs-N1 |
4.991800E-01 |
|
|
